References and Notes
<A NAME="RW11308ST-1A">1a</A>
Iizuka K.
Akahane K.
Momose DI.
Nakazawa M.
Tanouchi T.
Kawamura M.
Ohyama I.
Kajiwara I.
Ignchi Y.
Okada T.
Taniguchi K.
Miyamoto T.
Hayashi M.
J. Med. Chem.
1981,
24:
1139
<A NAME="RW11308ST-1B">1b</A>
Cozzi P.
Carganico G.
Fusar D.
Grossoni M.
Menichincheri M.
Pinciroli V.
Tonani R.
Vaghi F.
Salvati P.
J.
Med. Chem.
1993,
36:
2964
<A NAME="RW11308ST-1C">1c</A>
Lam PYS.
Vincent G.
Clark CG.
Deudon S.
Jadhav PK.
Tetrahedron Lett.
2001,
42:
3415
<A NAME="RW11308ST-2A">2a</A>
Chan DMT.
Monaco KL.
Wang RP.
Winters
MP.
Tetrahedron Lett.
1998,
39:
2933
<A NAME="RW11308ST-2B">2b</A>
Lam PYS.
Clark CG.
Saubern S.
Adams J.
Winters MP.
Chan DMT.
Combs A.
Tetrahedron Lett.
1998,
39:
2941
<A NAME="RW11308ST-3A">3a</A>
Collman JP.
Zhong M.
Org.
Lett.
2000,
2:
1233
<A NAME="RW11308ST-3B">3b</A>
Collman JP.
Zhong M.
Zeng L.
Costano S.
J. Org. Chem.
2001,
66:
1528
<A NAME="RW11308ST-3C">3c</A>
Collman JP.
Zhong M.
Zhang C.
Costanzo S.
J. Org. Chem.
2001,
66:
7892
<A NAME="RW11308ST-4">4</A>
Lam PYS.
Vincent G.
Clark CG.
Deudon S.
Jadhav PK.
Tetrahedron
Lett.
2001,
42:
3415
<A NAME="RW11308ST-5A">5a</A>
Antilla JC.
Buchwald SL.
Org. Lett.
2001,
3:
2077
<A NAME="RW11308ST-5B">5b</A>
Sasaki M.
Dalili S.
Yudin AK.
J.
Org. Chem.
2003,
68:
2045
<A NAME="RW11308ST-6A">6a</A>
Kantam ML.
Venkanna GT.
Sridhar C.
Sreedhar B.
Choudary BM.
J.
Org. Chem.
2006,
71:
9522
<A NAME="RW11308ST-6B">6b</A>
Dai Q.
Ran CZ.
Harvey RG.
Tetrahedron
2006,
62:
1764
<A NAME="RW11308ST-6C">6c</A>
Tzschucke CC.
Murphy JM.
Hartwig JF.
Org. Lett.
2007,
9:
761
<A NAME="RW11308ST-6D">6d</A>
Lan JB.
Zhang GL.
Yu XQ.
You JS.
Chen L.
Yan M.
Xie RG.
Synlett
2004,
1095
<A NAME="RW11308ST-7A">7a</A>
Havelková M.
Dvorřák D.
Hocek M.
Synthesis
2001,
1704
<A NAME="RW11308ST-7B">7b</A>
Havelková M.
Hocek M.
Cÿesnek M.
Dvorřák D.
Synlett
1999,
1145
<A NAME="RW11308ST-8A">8a</A>
Bellina F.
Carpita A.
Rossi R.
Synthesis
2004,
2419
<A NAME="RW11308ST-8B">8b</A>
Kotha S.
Lahiri K.
Kashinath D.
Tetrahedron
2002,
58:
9633
<A NAME="RW11308ST-8C">8c</A>
Hassan J.
Sevignon M.
Gozzi C.
Schulz E.
Lemaire M.
Chem.
Rev.
2002,
102:
1359
<A NAME="RW11308ST-9">9</A>
Korenaga T.
Kadowaki K.
Ema T.
Sakai T.
J. Org. Chem.
2004,
69:
7340
<A NAME="RW11308ST-10A">10a</A>
Korenaga T.
Kosaki T.
Fukumura R.
Ema T.
Sakai T.
Org. Lett.
2005,
7:
4915
<A NAME="RW11308ST-10B">10b</A>
Chen J.
Cammers GA.
Tetrahedron Lett.
2003,
44:
1503
<A NAME="RW11308ST-10C">10c</A>
Takimiya K.
Niihara N.
Otsubo T.
Synthesis
2005,
1589
<A NAME="RW11308ST-11A">11a</A>
Chanbers RD.
Chivers T.
J.
Chem. Soc.
1965,
3933
<A NAME="RW11308ST-11B">11b</A>
Frohn HJ.
Adomin NY.
Bardin VV.
Starichenko VF.
Z.
Anorg. Allg. Chem.
2002,
628:
2834
<A NAME="RW11308ST-12A">12a</A>
Lam PYS.
Clark CG.
Saubern S.
Adams J.
Averill K.
Chan DMT.
Combs AP.
Synlett
2000,
674
<A NAME="RW11308ST-12B">12b</A>
Evans DA.
Katz JL.
West TR.
Tetrahedron Lett.
1998,
39:
2937
<A NAME="RW11308ST-13">13</A>
Platonov VE.
Haas A.
Schelvis M.
Lieb M.
Dvornikova KV.
Osina OI.
J. Fluorine Chem.
2002,
116:
3
<A NAME="RW11308ST-14">14</A>
Typical Procedure
for the Preparation of Compound 3b
Copper(II) acetate
(0.2 mmol) was added to a stirred mixture of EtOAc (15 mL) and pentafluorophenylboronic
acid (1.5 mmol). The mixture was stirred for 10 min at r.t. then
the 4-chlorophenylamine (1.0 mmol) was slowly added to the mixture.
The reaction mixture was stirred sequentially for 5 h under
the atmosphere of oxygen. The reaction was monitored by TLC and
quenched with H2O (5 mL). The resulting mixture was filtrated
through a pad of Celite and the filtrate was extracted with EtOAc
(3 × 15 mL). The combined organic layers were dried over
Na2SO4, filtered, and concentrated under reduced
pressure to give a crude product, which was purified by column chromatography
to give N-(4-chlorophenyl)-2,3,4,5,6-pentafluoroaniline
(3b). Light yellow crystals; mp 78.5-79.8 ˚C.
IR (KBr): 3417, 3133, 1524, 1495, 1399 cm-¹. ¹H
NMR (500 MHz, CDCl3): δ = 5.39
(br, 1 H), 6.75 (d, 2 H, J = 7.5
Hz), 7.23 (d, 2 H, J = 7.0
Hz). ¹³C NMR [100 MHz, CDCl3 (except
for C6F5)]: δ = 117.7
(2 × CH), 126.9, 129.2 (2 × CH), 140.7. ¹9F
NMR (376 MHz, CDCl3): δ = -158.98
(t, 1 F, J = 21.4
Hz),
-158.57 (dd, 2 F, J
1 = 21.4
Hz, J
2 = 21.4
Hz), -145.46 (d, 2 F, J = 19.6
Hz). MS (EI): m/z (%) = 293
(8) [M+], 273 (4), 238 (8),
151 (100), 88 (38). HRMS (EI): m/z calcd
for C12H5ClF5N: 293.0031; found:
293.0030.
<A NAME="RW11308ST-15">15</A>
Typical Procedure
for the Preparation of Compound 7a
Copper(II) acetate
(1 mmol) was added to a stirred mixture of DMF (25 mL) and pentafluorophenylboronic
acid (2 mmol). The mixture was stirred for 10 min at r.t. then the Et2NH
(1.0 mmol) were slowly added to the mixture. The reaction mixture
was stirred sequentially for 12 h under the atmosphere of oxygen.
The reaction was monitored by TLC and quenched with H2O
(5 mL). The resulting mixture was filtrated through a pad of Celite,
and the filtrate was extracted with EtOAc (3 × 15 mL).
The combined organic layers were dried over Na2SO4,
filtered, and concentrated under reduced pressure to give a crude
product, which was purified by column chromatography to give N,N-diethyl-2,2′,3,3′,4′,5,5′,6,6′-nonafluorobiphenyl-4-amine
(7a). Light yellow crystal; mp 71.6-72.5 ˚C.
IR (KBr): 2976, 2917, 1644, 1503, 1384, 1046 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 1.16
(t, 6 H, J = 7.2
Hz), 3.33 (q, 4 H, J = 7.2 Hz). ¹³C NMR [100
MHz, CDCl3 (except for C12F9)]: δ = 13.4
(2 × CH), 46.8 (2 × CH). ¹9F
NMR (376 MHz, CDCl3): δ = -157.56
to -157.43 (m, 2 F), -147.96 (t, 1 F, J = 21.4 Hz), -145.62
to -145.568 (m, 2 F), -137.16 to
-137.09
(m, 2 F), -133.91 to -133.83 (m, 2 F). MS (EI): m/z (%) = 387
(25) [M+], 358 (15), 372 (100),
344 (75). HRMS (EI): m/z calcd
for C16H10F9N: 387.0670; found:
387.0672.